GAMUNEX-C
Dead / Cancelled — Cancelled — Section 8 (as of 19 Jan 2018)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 85011751
- Registration number
- 3979311
- Mark type
- Stylized text
- Filed
- 12 Apr 2010
- Published for opposition
- 07 Sept 2010
- Registered
- 14 Jun 2011
- Attorney of record
- Paul Fields
Goods and services
- Class 005 — Pharmaceuticals: Immune serum globulin
Owner
- GRIFOLS THERAPEUTICS LLC, LOS ANGELES, CA, US
- GRIFOLS THERAPEUTICS INC., RESEARCH TRIANGLE PARK, NC, US
- Talecris Biotherapeutics, Inc., Research Triangle Park, NC, US
- Talecris Biotherapeutics, Inc., Research Triangle Park, NC, US
- Talecris Biotherapeutics, Inc., Research Triangle Park, NC, US
Prior registrations
Prosecution history
- 31 Jan 2018 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 19 Jan 2018 — CANCELLED SEC. 8 (6-YR)
- 22 Feb 2017 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 14 Jun 2016 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 19 Apr 2016 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 19 Apr 2016 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 05 Mar 2014 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 14 Nov 2012 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 14 Jun 2011 — REGISTERED-PRINCIPAL REGISTER
- 10 May 2011 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 09 May 2011 — LAW OFFICE REGISTRATION REVIEW COMPLETED
- 06 May 2011 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 06 May 2011 — ASSIGNED TO EXAMINER
- 04 May 2011 — STATEMENT OF USE PROCESSING COMPLETE
- 02 May 2011 — USE AMENDMENT FILED